Codex DNA

United States
Wonewoc, Wisconsin, United States, 92121-2993

Company profile

Codex DNA company profile

Codex DNA is a biology company helping researchers with the tools they need to securely design, code, and create synthetic DNA. The company is on a mission to help scientific researchers in both academic and commercial settings with the hardware, software, materials, and methodologies required to rapidly and accurately write large quantities of synthetic genes. To, in effect, build biology. Its gene synthesis portfolio reduces the turnaround time for synthesizing workflows from weeks and months to days and hours and includes the BioXp system, DNA services, Gibson Assembly reagents, and Vmax chemically competent cells. In addition to automating, speeding, and optimizing DNA design and synthesis, Codex DNA and the BioXp system ensure your designs stay in your hands, marrying speed and security for innovators in drug discovery, vaccine development, precision medicine, and beyond. Co-founded by Dan Gibson — the creator of the industry-standard Gibson Assembly methodology — Codex DNA is attempting nothing less than changing everything.

Business identity

Contact email
[email protected]
Phone number
+1 858 228 4115
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2011-01-01, Year

Headquarters

Postal code
92121-2993
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
1
Total equity funding
$25M
Last funding
Series A / $25M / 2019-09-09
Last equity funding
Series A / $25M
Investors
3
Lead investors
1
Founders
2
Articles
29
Exited on
2021-06-18

Founders and investors

Founders

Dan GibsonTodd Nelson

Lead investors

Northpond Ventures

Investors

BroadOak Capital PartnersNorthpond VenturesOxford Finance LLC